This Article Full Text Full Text (PDF) All Versions of this Article: 106/19/2448    most recent 01.CIR.0000036746.49449.64v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Staudt, A. Articles by Felix, S. B. Search for Related Content PubMed PubMed Citation Articles by Staudt, A. Articles by Felix, S. B. Related Collections Myocardial cardiomyopathy disease Other Treatment

(Circulation. 2002;106:2448.)
© 2002 American Heart Association, Inc.

Clinical Investigation and Reports

Potential Role of Autoantibodies Belonging to the Immunoglobulin G-3 Subclass in Cardiac Dysfunction Among Patients With Dilated Cardiomyopathy

Alexander Staudt, MD; Marko Böhm, MD; Fabian Knebel, MD; Yvonne Grosse, MD; Claudia Bischoff, MD; Astrid Hummel, MD; Johannes B. Dahm, MD; Adrian Borges, MD; Nicoline Jochmann, MD; Klaus D. Wernecke, PhD; Gerd Wallukat, PhD; Gert Baumann, MD; Stephan B. Felix, MD

From Klinik für Innere Medizin B, Ernst-Moritz-Arndt-Universität (A.S., Y.G., C.B., A.H., J.B.D., S.B.F.), Greifswald, Germany; Medizinische Klinik I, Charité, Humboldt-Universität (M.B., F.K., A.B., N.J., G.B.), Berlin, Germany; Institut für Medizinische Biometrie, Charité, Humboldt-Universität (K.D.W.), Berlin, Germany; and Max-Delbrück-Zentrum für Molekulare Medizin (G.W.), Berlin, Germany.

Correspondence to Stephan B. Felix, MD, Klinik für Innere Medizin B, Ernst-Moritz-Arndt-Universität, Friedrich-Loefflerstraße 23a, 17487 Greifswald, Germany. E-mail felix{at}mail.uni-greifswald.de

Background— Immunoadsorption capable of removing circulating autoantibodies represents an additional therapeutic approach in dilated cardiomyopathy (DCM). The role played by autoantibodies belonging to the immunoglobulin (Ig) subclass G-3 in cardiac dysfunction remains to be elucidated.

Methods and Results— Patients with DCM (left ventricular ejection fraction <30%) participated in this case-control study. Nine patients underwent immunoadsorption with protein A (low affinity to IgG-3), and 9 patients were treated with anti-IgG, which removes all IgG subclasses. Immunoadsorption was performed in 4 courses at 1-month intervals until month 3. In the 2 groups, immunoadsorption induced comparable reduction of total IgG (>80%). IgG-3 was effectively eliminated only by anti-IgG adsorption (eg, during the first immunoadsorption course; protein A, -37±4%; anti-IgG, -89±3%; P<0.001 versus protein A). The ß₁-receptor autoantibody was effectively reduced only by anti-IgG (P<0.01 versus protein A). Hemodynamics did not change in the protein A group. In the anti-IgG group during the first immunoadsorption course, cardiac index increased from 2.3±0.1 to 3.0±0.1 L · min^-1 · m^-2 (P<0.01 versus protein A). After 3 months, before the last immunoadsorption course, cardiac index was 2.2±0.1 L · min^-1 · m^-2 in the protein A group and 3.0±0.2 L · min^-1 · m^-2 in the anti-IgG group (P<0.01 versus protein A). Left ventricular ejection fraction increased only in the anti-IgG group (P<0.05 versus protein A).

Conclusions— Autoantibodies belonging to IgG-3 may play an important role in cardiac dysfunction of DCM. The removal of antibodies of the IgG-3 subclass may represent an essential mechanism of immunoadsorption in DCM.

Key Words: cardiomyopathy • immunoadsorption • antibodies

This article has been cited by other articles:

				S. Gupta Heartache of Fc Receptors J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1693 - 1695. [Full Text] [PDF]

				A. Staudt, P. Eichler, C. Trimpert, S. B. Felix, and A. Greinacher Fc{gamma} Receptors IIa on Cardiomyocytes and Their Potential Functional Relevance in Dilated Cardiomyopathy J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1684 - 1692. [Abstract] [Full Text] [PDF]

				Y. Matsumoto, I.-K. Park, and K. Kohyama B-Cell Epitope Spreading Is a Critical Step for the Switch from C-Protein-Induced Myocarditis to Dilated Cardiomyopathy Am. J. Pathol., January 1, 2007; 170(1): 43 - 51. [Abstract] [Full Text] [PDF]

				A L. Caforio, L Daliento, A Angelini, S Bottaro, A Vinci, G Dequal, F Tona, S Iliceto, G Thiene, and W J McKenna Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies Lupus, September 1, 2005; 14(9): 652 - 655. [Abstract] [PDF]

				M G. Gagliardi, M Bevilacqua, C Bassano, B Leonardi, R Boldrini, F D. Camassei, A Fierabracci, A G Ugazio, and G F Bottazzo Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy Heart, October 1, 2004; 90(10): 1167 - 1171. [Abstract] [Full Text] [PDF]

				J. M. Davison, V. Homuth, A. Jeyabalan, K. P. Conrad, S. A. Karumanchi, S. Quaggin, R. Dechend, and F. C. Luft New Aspects in the Pathophysiology of Preeclampsia J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2440 - 2448. [Abstract] [Full Text] [PDF]

				A. Staudt, Y. Staudt, M. Dorr, M. Bohm, F. Knebel, A. Hummel, L. Wunderle, M. Tiburcy, K. D. Wernecke, G. Baumann, et al. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy J. Am. Coll. Cardiol., August 18, 2004; 44(4): 829 - 836. [Abstract] [Full Text] [PDF]

				A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy Eur. Heart J., July 1, 2004; 25(13): 1108 - 1115. [Abstract] [Full Text] [PDF]